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Abstract. Finding the arrythmogenic potential in patients with arterial hypertension as well as its correlation with left 
ventricular hypertrophy (LVH), and its type and degree. The research included 109 hypertensive patients (pts) (54 male 
and 55 female), 54.2 ± 7.9 years old  without symptomatic coronary disease, myocardial infarction and  systolic 
dysfunction. All the pts had a clinical examination, ECG, 24 h Holter monitoring with Lown classification of ventricular 
arrhythmias, an echocardiogram with left ventricular mass index (LVMI) and a specific type of LVH. QT interval 
dispersion (QTd) was calculated on 12 leads standard ECG. 75 pts had LVH (LVMI: 172.6 ± 42.95 g/m2) while 35 pts 
were without LVH (109.3 ± 15.9 g/m2). Non sustained ventricular tachycardia was registered in 13 pts (17.6%) with 
LVH and 1 female patient without LVH (2.9%). Patients with VT had a considerably higher ILVM (214.9 ± 6.8 vs. 151.9 
± 47.2 g/m2) than the average and higher QTd (73.7 ± 19.1 vs. 55.2 ± 20.2). VT was registered in 3/19 (15.8%) with 
eccentric nedilated type LVH, 6/38 (15.8%) with concentric LVH, 1/11 (9.1) (disproportional septal LVH) and 3/5 ( 60%) 
with dilated LVH. Univariate analysis showed a considerable correlation between the degree of arrhythmias and ILVM 
(p<0.001) and QTd (p=0.012). Ventricular arrhythmias in patients with arterial hypertension are considerably 
correlated to the degree of LVH expressed in ILVM and QTd. 
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Introduction 

 
The increased thickness of the left ventricular wall and 
enlargement of the left ventricular cavity that may 
accompany hypertension have a compensatory value in 
that the heart is better able to maintain stroke volume in 
the face of an increased afterload. As the structural 
changes progress, however, cardiac function diminishes 
and either concentric and eccentric left ventricular 
hypertrophy (LVH) develops. The change represents an 
additional risk factor for all types of cardiovascular 
disease in hypertensive patients 1. 
Left ventricular hypertrophy on the electrocardiogram 
(ECG) has been identified as a major risk factor for 
cardiovascular disease for more than 35 years. The data 
from the Framingham Heart Study also showed that the 
detection of LVH by echocardiography provides 
persuasive prognostic information beyond that derived 
from traditional risk factors such as blood pressure, 
smoking, and lipid levels. In that study as well as in the 
investigation carried out at the New York Hospital-Cornell 
Medical Center, left ventricular mass and age were the 
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strongest predictors of prognosis 2. The importance of 
LVH is confirmed by the finding that, within 5 years of its 
appearance, one-third of men and one-fourth of women 
with LVH are dead 3.  
A multivariate analysis demonstrated in men a relative 
risk of death from cardiovascular disease of 1.73 for each 
increment of 50 g/m
2
 in left ventricular mass. The 
corresponding value for women was 2.12. The risk factor-
adjusted relative risk of sudden death in men was for each 
increment of 50 g/m
2
 in left ventricular mass. In a report 
restricted to patients with essential hypertension, the 
multivariate analysis showed that only age and 
echocardiographic left ventricular mass were 
independently associated with the cardiovascular death 4. 
Analyzing patho-anatomic and electrophysiological 
characteristics of myocardium in LVH it can be shown 
that hypertensive myocardium has a tendency to show 
electric instability and arrhythmias. The hypothesis of 
hypertrophy per se leading to electrophysiological 
changes that may trigger lethal arrhythmias may be even 
more attractive.  
It has been suggested that the increased incidence of 
sudden death in hypertensive patients, particularly those 
with LVH, may be casually related to the increased 
number and complexity of ventricular arrhythmias that 
have been demonstrated in these patients. 
Electrophysiological studies suggest that QT 
prolongation is associated with increased regional 
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homogeneity of repolarization, a factor that may contribute 
to ventricular arrhythmias. Recent clinical studies have 
suggested that the interload variability of the QT interval in 
the standard ECG, defined as QT dispersion, reflects 
regional differences in ventricular repolarization. Increased 
dispersion of recovery time is believed to increase the risk 
for serious ventricular arrhythmias. 5,6,7. 
In view of this, the aim of our study is to prove whether 
there is an interrelation between markers of sudden death 
in hypertensive  patients (left ventricular hypertrophy, its 
degree and type, ventricular arrhythmias and QTc 
dispersion). 
Subjects and Methods 
Subjects 
One hundred and nine consecutive hypertensive patients 
(pts) (54 male and 55 female), 54.2  7.9 years old, treated 
at the Health Center for Hypertension at the Institute 
"Niska Banja", were involved in the study. To be included, 
patients must have trough sitting diastolic blood pressure 
mean readings of 90 to 115 mmHg or sitting systolic blood 
pressure mean readings of 160 to 200 mmHg after 1 and 2 
weeks without antihypertensive therapy. Patients were 
excluded if they had clinical or laboratory evidence of 
heart failure, renal failure, coronary artery disease, valvular 
defect, or secondary causes of hypertension. 
Electrocardiography 
Standard 12-lead ECGs were recorded with a paper 
speed of 25 or 50 mm/s. ECGs of technically good 
quality were recorded. QT interval analysis was done on 
12-lead ECGs taken upon enrolment in the study 8. A 
single observer measured QT interval in all leads, if 
possible, on a surface 12-lead ECG (25 mm/s speed). 
QT interval was taken from onset of the QRS to the end 
of the T wave (i.e., return to the T/P baseline). If U 
waves were present, the QT interval was measured to 
the nadir of the curve between the T and U waves. 
Three consecutive cycles were measured for each lead. 
QT intervals were corrected with Basset's formula 
(QTc=QT/RR sup 1/2). QTc dispersion, defined as the 
difference between maximum and minimum QTc, was 
calculated in ECGs in which at least 5 leads were 
measurable. Adjusted QTc dispersion was measured to 
correct for the known dependence of the index on the 
number of measurable leads 9. 
Echocardiography  
The echocardiographic studies were performed in the 
morning, with the subject in a supine left lateral decubitus 
position, after 30 minutes of rest. Only one physican was 
responsible for recording the echocardiogram. The 
measurements of left ventricular wall thickness and 
chamber diameter were made in diastole in accordance 
with methods outlined by the American Society of 
Echocardiography 10. Left ventricular mass (LV mass) 
was estimated by the modified cubed formula using 
measurements obtained in accordance with the "Penn" 
convention 11: LV mass (g) = 1.04 (LVID + VST + 
PWT)
3  (LVID)3  13.6, where LVID is left ventricular 
internal dimension, VST is ventricular septal thickness, 
and PWT is posterior left ventricular wall thickness. LV 
mass indexed by body surface area (g/m
2
). Cut-off values 
for LVH by Penn convention (g/m
2
) criteria were 134 
g/m
2
 for men and 110 g/m2 for women. Left ventricular 
wall thickness was defined as sum VST and PWT, 
relative wall thickness was defined as (left ventricular 
wall thickness/LVID)x100% and index LVID (LVID/ 
body surface area). On the basis of these parameters 4 
types of LVH are defined: 1) concentric hypertrophy-C; 
2) eccentric no dilated LVH - END, 3) eccentric dilated 
LVH - ED and 4) disproportional septal LVH - DS 12. 
Ambulatory electrocardiographic monitoring 
Twenty-four hour ambulatory ECGs were recorded with 
sistem Del Mar Avionics, model 465; Irvine, California 
during each subject's normal activities. Evaluation of 
premature ventricular complex followed the grading 
system of Lown and Wolf 13. Grade 0, no premature 
ventricular complex; Grade 1,<30 premature ventricular 
complex/h; Grade 2, >30 premature ventricular complex/h; 
Grade 3, multiform prematureventricular complex; Grade 
4A, couplets; Grade 4B, run of ventricular tachycardia 
(VT) (3 or more consecutive premature ventricular 
complex). Lown Grade 3 were considered as complex 
ventricular arrhythmias. Since the classification suggested 
by Lown and Wolf combines prevalence with morphology 
of ventricular ectopy, in a second analysis we compared 
hypertensive patients with complex ventricular ectopy with 
those without commplex ventricular ectopy. 
Statistical analysis 
The data from individual patients were summarized as 
mean  SD. The statistical significance of differences in 
correlation coefficients and mean values was examined by 
ANOVA and by Student's t test for unpaired observations. 
A value of P<0.05 was taken as the minimal level of 
statistical significance. Statistical tests were carried using 
STATISTICA programs. 
Results 
From 109 hypertensive patients included in this study, 74 
pts had echocardiographic evidence of left ventricular 
hypertrophy while 35 did not. There were no differences 
between the groups in terms of sex, body surface area and 
cholesterol degree. Systolic blood pressure, left ventricular 
mass index, the frequency of ventricular tachycardia and 
QTc dispersion were statistically significantly higher 
(p<0.05) in the patients with echocardiographic LV 
hypertrophy (Table 1). 
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Type left ventricular hypertrophy 
Most hypertensive pts had LVH of a concentric type, 
while a small but significant group of pts had a dilated 
LVH. This group was significantly different from the pts 
with other LVH types since they were older, they had 
lower systolic blood pressure, a high degree LVH (LV 
mass index: 260  62.5 g/m2), proportionally greater 
frequency of ventricular tachycardia and bigger QTc 
dispersion (Table 2). The examined parameters did not 
show any other significant differences in patients with 
other LVH types except for the fact that the patients with 
disproportional septal LVH were younger, had lower 
systolic blood pressure and lower LV mass index. 
Relationship between left ventricular mass index and 
examined parameters  
Systolic blood pressure (r = 0.27, p = 0.0047) and heart 
rate (r = 0.25, p = 0.016) are closely connected to the 
degree of left ventricular hypertrophy. The interconnection 
is even more prominent between left ventricular mass 
index and QTc dispersion (r = 0.34, p = 0.004). The 
frequency of ventricular arrhythmias graded according to 
Lown-Wolf is strictly correlated with seriousness of left 
ventricular hypertrophy (r = 0.4, p = 0.00002) (Table 3). 
Table 3 Correlation coefficients relating clinical  
and haemodynamic data to left ventricular 
mass index 
 ILVM 
Age (yr) 
Body surface area (m
2
) 
Systolic pressure (mm Hg) 
Diastolic pressure (mm Hg) 
Heart rate (beats/min) 
Lown-Wolf degree 
QTc ms 
QTc dispersion 
Cholesterol 
0.17 
0.13 
0.27
**
 
0.07 
0.25
*
 
0.4
***
 
0.14 
0.34
**
 
0.03 
*p<0.05, **p<0.005, ***p<0.001 
Fig 1 and Table 4 show significant correlation 
between two examined markers of sudden death in our 
study. More serious degree of ventricular arrhythmias 
was accompanied by longer QTc, bigger QT dispersion 
and higher LV mass index. 
Table 1  Clinical and hemodynamic characteristics of hypertensive patients with and  
without left ventricular hypertrophy established by echocardiographically. 
                                                     Echo LVH (n=74) Echo no LVH (n=35) 
Age (yr) 55.3  7.8*  51.7  7.5 
Body surface area (m
2
) 1.91  0.2   1.87  0.2 
Sex (male:female ratio) 38/36 16/19 
Systolic pressure (mm Hg) 169.4  16**   158.1  12.7 
Diastolic pressure (mm Hg) 106.6  15     104.6  7      
Heart rate (beats/min) 75.1  9     72.9  8.2 
Left ventricular mass index g/m
2
 172.6  43**   109.3  16    
IVb degree Lown (n) 13 (18%)
*
 1(3%) 
QTc ms 434.6  28.5  421  31 
QTc dispersion 58.8  20* 48.3  20  
Cholesterol   6.2  1.1     6.1  21.3 
Values are expressed as means  SEM , * p<0.05, ** p<0.01 
Table 2 Clinical and hemodynamic characteristics of hypertensive patients with different types of LVH 
 C LVH (n=38) END LVH (n=19) ED LVH (n=6) DS LVH (n=11) 
Age (yr) 54.6 7.3    56.9  8.6   61.2  4.8 51.4  8.3 
Body surface area (m
2
) 1.87  0.15 1.9  0.2 1.96  0.1 1.92  0.1 
Sex (male:female ratio) 16/22 11/8 6/0 6/5 
Systolic pressure (mm Hg) 172  16   169.5  18.4   162  15 160.5  12    
Diastolic pressure (mm Hg) 109.6  10      105.3  11       103  4.5 106.8  6.4   
Heart rate (beats/min)  75  8.6 73.1  10    82.5  13  77.2  8    
Left ventricular mass index g/m
2 
166.8  40.3   172.4  23          260  62.5* 152.7  21.5 
IVb degree Lown (n) 6 (16%) 3 (16%) 3 (50%) 1 (9%) 
QTc ms 433.3  25.2    430.8  35.1    461.7  24      442  28.1 
QTc dispersion 54.3  14.1    62  20.1   92.5  38.4 58.2  11   
Cholesterol 6.12  1.1    6.7  1       5.9  1.6 6.15  1.2  
Values are expressed as means  SEM , * p<0.05 
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Fig. 1 Scatter plots illustrating the relationship of the 
premature ventricular complexes (Lown-Wolf) 
to the QT dispersion. 
Table 4 Relationship between dispersion parameters and 
the grade of premature ventricular complexes. 
 02* 34 
LVM index 144  35.3** 185.2  58.5 
QTc 425.7  28.4**     443.5  27.3 
QTc dispersion 52.15  18**           64  21 
Values are expressed as means  SEM , *Lown-Wolf grades 
0,1,2 vs. Lown-Wolf grades 3,4A,4B 
** p<0.05 
In 14 (13%) hypertensive patients non-sustained 
ventricular tachycardia was registered. Almost all 
patients were male but in other clinical parameters (age, 
body surface area, blood pressure and heart rate, 
cholesterol) they did not show any difference from other 
patients. However, the degree of their hypertrophy and 
QTc dispersion were significantly different compared to 
pts who did not have VT (Table 5). 
Table 5 Clinical characteristics of patients with 
registered VT. 
Age (yr) 57.4  9      
Body surface area (m
2
) 1.9  0.1 
Sex (male:female ratio) 10/3 
Systolic pressure (mm Hg) 168.6  18       
Diastolic pressure (mm Hg) 108.2  12       
Heart rate (beats/min) 76.9  12.1  
Left ventricular mass index g/m
2 
214.9  68.4    
QTc ms 442.3  28       
QTc dispersion 73.7  19     
Cholesterol 6.1  1.4  
Values are expressed as means  SEM, 
Discussion 
Our research shows that the increase of left ventricular 
mass is closely correlated with frequency of ventricular 
arrhythmias and QTc dispersion. Knowing the importance 
of ventricular arrhythmias and QTc dispersion as markers 
of sudden death, our results suggest that identification of 
left ventricular mass in hypertensive pts is a good marker 
for future prognosis. 
The importance of LV hypertrophy in the morbidity of 
hypertensive disease has been underscored by the number 
of electrocardiographic and echocardiographic studies that 
have convincingly demonstrated its importance as an 
independent predictor of morbidity and mortality 14,15. 
Not only does LV hypertrophy as a dichotomous variable 
predict adverse outcome, but the magnitude of LV mass a 
continuous variable is also associated with cardiovascular 
risk, even with values for LV mass within the "normal 
range". 
Importantly, there is an association of LV hypertrophy 
with complex ventricular arrhythmia, a possible processor 
of sudden death in hypertensive patients, even in patients 
without coronary artery disease on angiography 16. In 
patients with reversible myocardial perfusion defects 
on thallium scintigraphy, both LV hypertrophy and 
inducible ischemia are independently associated with 
ventricular arrhythmias 17. Using programmed electrical 
stimulation, Coste et al. 18 demonstrated more 
intraventricular reentry and non-sustained ventricular 
tachycardia in hypertensive patients with LV hypertrophy 
compared to control group. 
The pathologic alternant related to ectopic impulse 
generation in LVH are multifactorial 19 and include 
enlarged myocytes, the expansion of the collagen matrix, 
fibrosis, subendocardial ischemia, and medial hypertrophy 
of the coronary arteries impending homogeneous impulse 
propagation throughout the myocardium. The 
arrhythmogenic substrate of LV hypertrophy itself may 
explain reentry mechanisms, such as fibrillar stretching, 
anisotropy, and triggered activity due to after-potentials, 
depending on activation of slow calcium channels. 
Concentric hypertrophy appears to be associated with a 
more severe overall prognosis compared with eccentric 
hypertrophy, whereas concentric remodeling seems to be 
of intermediate significance compared with normal 
geometry 20. Eccentric LV hypertrophy was 
independently associated with increased risk of sudden 
cardiac arrest (SCA) in subjects with EF ≤40% 21. In our 
study there was no (statistical) difference in arrhythmias 
between these two types of LV hypertrophy, however, 
significantly highest incidence of serious arrhythmia, 
despite the small number of patients, was registered in 
patients with ED type. These patients had the highest QT 
dispersion and the greatest left ventricular mass index. 
QT dispersion has been associated with increased risk 
for ventricular arrhythmias and sudden death in patients 
with chronic heart failure 9, mitral valve prolapse 22, 
MI 23, familial long-QT syndrome 24, and with an 
increased risk for cardiac mortality in patients with 
peripheral arterial disease, MI and older men and women 
25. 
Clarkson et al. in their study of multivariate analyses 
demonstrated significant relationships between QT 
dispersion and office systolic blood pressure, and left 
ventricular mass index. Several studies reported that the 
most typical electrical abnormality associated with 
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cardiac hypertrophy is prolongation of the action 
potential. Left ventricular hypertrophy by severe 
hypertension induced by renal artery constriction 
produced a prolongation of action potential duration. An 
increased dispersion of ventricular refractoriness might 
represent another electrical consequence of the 
hypertrophic process. A prolonged duration of ventricular 
repolarization, in fact may be proarrhythmic, probably 
favoring the occurrence of after depolarizations and then 
triggering activity-related arrhythmias 26,27.  
The results of our study have shown that QTc 
dispersion is significantly correlated with the increase of 
left ventricular mass index and that the highest values are 
found in pts with eccentric nondilated and eccentric dilated 
which proves the hypothesis that an important entity 
underlying QT dispersion is patchy myocardial fibrosis, 
resulting from ventricular dilatation and neurohormonal 
activation and myocardial ischemia.  
The results of our study have shown a significant 
correlation between QTc dispersion and the degree of 
ventricular arrhythmias registered by Holter monitoring. 
It can be important for better understanding not only of 
the mechanisms of malignant arrhythmias in pts with 
LV hypertrophy (QTc dispersion shows differences in 
action potential duration) but also in estimating the risk 
that a hypertensive patient carries with himself.  
Modern antihypertensive therapy means, among other 
things, a possibility of regression of left ventricular mass 
index. Recent studies prove that there is a chance of better 
prognosis in pts with regression of LV hypertrophy but 
there is not a study which shows what the arrhythmogenic 
potential of myocardium is after its regression. The 
observation of left ventricular mass, ventricular 
arrhythmias and QTc dispersion can probably answer the 
question to what degree and how regression of left 
ventricular hypertrophy are correlated with decrease of 
electric vulnerability of myocardium and with a risk of 
sudden death in this group of pts. 
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